Evidence map›Paper›PMID 40868301›Full record

ArticleBioengineering (Basel, Switzerland)2025

High-Throughput Microfluidic Electroporation (HTME): A Scalable, 384-Well Platform for Multiplexed Cell Engineering.

William R Gaillard, Jess Sustarich, Yuerong Li, David N Carruthers, Kshitiz Gupta, Yan Liang, Rita Kuo, Stephen Tan, Sam Yoder, Paul D Adams and 3 more

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

William R GaillardDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.
Jess SustarichDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.
Yuerong LiDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.
David N CarruthersDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0000-0002-8275-2278
Kshitiz GuptaDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0000-0002-1732-6176
Yan LiangDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.
Rita KuoDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.
Stephen TanDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.
Sam YoderDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.
Paul D AdamsDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.
Hector Garcia MartinDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0000-0002-4556-9685
Nathan J HillsonDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0000-0002-9169-3978
Anup K SinghDOE Joint BioEnergy Institute, Emeryville, CA 94608, USA.

Funding

United States Department of Energy DE-AC02-05CH11231
6 · The paper itself

Abstract

Electroporation-mediated gene delivery is a cornerstone of synthetic biology, offering several advantages over other methods: higher efficiencies, broader applicability, and simpler sample preparation. Yet, electroporation protocols are often challenging to integrate into highly multiplexed workflows, owing to limitations in their scalability and tunability. These challenges ultimately increase the time and cost per transformation. As a result, rapidly screening genetic libraries, exploring combinatorial designs, or optimizing electroporation parameters requires extensive iterations, consuming large quantities of expensive custom-made DNA and cell lines or primary cells. To address these limitations, we have developed a High-Throughput Microfluidic Electroporation (HTME) platform that includes a 384-well electroporation plate (E-Plate) and control electronics capable of rapidly electroporating all wells in under a minute with individual control of each well. Fabricated using scalable and cost-effective printed-circuit-board (PCB) technology, the E-Plate significantly reduces consumable costs and reagent consumption by operating on nano to microliter volumes. Furthermore, individually addressable wells facilitate rapid exploration of large sets of experimental conditions to optimize electroporation for different cell types and plasmid concentrations/types. Use of the standard 384-well footprint makes the platform easily integrable into automated workflows, thereby enabling end-to-end automation. We demonstrate transformation of

Indexed as

automationelectroporationhigh-throughputmicrofluidicself-driving labstrain engineeringsynthetic biologytransfectiontransformation

Identifiers

PMID40868301
PMCPMC12383916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.